Position in CCCC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,778,500
+$9,277,258 QoQ
Shares Held
2,522,163
+165.2% QoQ
Ownership
2.05%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. CCCC ranks #176 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CCCC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,778,500 | 2,522,163 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,501,242 | 951,043 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,888,756 | 988,878 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,610,174 | 725,304 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,065,425 | 745,053 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,288,460 | 1,430,288 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,971,909 | 1,381,086 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $7,807,152 | 1,369,676 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,293,437 | 1,362,216 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $4,169,273 | 510,315 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,724,927 | 482,288 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $847,869 | 455,844 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,207,137 | 438,959 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,640,042 | 840,778 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,704,022 | 797,292 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,816,236 | 777,222 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,439,544 | 721,425 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $16,201,288 | 667,819 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $22,094,867 | 686,176 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $29,771,311 | 666,323 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $17,048,509 | 450,542 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,123,978 | 192,592 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $6,269,885 | 189,251 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||